These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25991485)

  • 1. Parametric response mapping of dynamic CT for predicting intrahepatic recurrence of hepatocellular carcinoma after conventional transcatheter arterial chemoembolization.
    Choi SJ; Kim J; Seo J; Kim HS; Lee JM; Park H
    Eur Radiol; 2016 Jan; 26(1):225-34. PubMed ID: 25991485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
    Choi SJ; Kim J; Seo J; Kim HS; Lee JM; Park H
    Abdom Imaging; 2014 Jun; 39(3):518-25. PubMed ID: 24519566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parametric response mapping cut-off values that predict survival of hepatocellular carcinoma patients after TACE.
    Nörthen A; Asendorf T; Shin HO; Hinrichs JB; Werncke T; Vogel A; Kirstein MM; Wacker FK; Rodt T
    Abdom Radiol (NY); 2018 Dec; 43(12):3288-3300. PubMed ID: 29680967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric response mapping of dynamic CT: enhanced prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Choi SJ; Kim J; Kim HS; Park H
    Abdom Radiol (NY); 2017 Jul; 42(7):1871-1879. PubMed ID: 28204855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings.
    Park HJ; Kim JH; Choi SY; Lee ES; Park SJ; Byun JY; Choi BI
    AJR Am J Roentgenol; 2017 Oct; 209(4):W211-W220. PubMed ID: 28813195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE.
    Hinrichs JB; Shin HO; Kaercher D; Hasdemir D; Murray T; Kaireit T; Lutat C; Vogel A; Meyer BC; Wacker FK; Rodt T
    Eur Radiol; 2016 Oct; 26(10):3447-55. PubMed ID: 26769666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of recurrent hepatocellular carcinoma in cirrhotic liver after transcatheter arterial chemoembolization: value of quantitative color mapping of the arterial enhancement fraction of the liver.
    Lee DH; Lee JM; Klotz E; Kim SJ; Kim KW; Han JK; Choi BI
    Korean J Radiol; 2013; 14(1):51-60. PubMed ID: 23323031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic results of computed-tomography-guided transcatheter arterial chemoembolization for local recurrence of hepatocellular carcinoma after initial transcatheter arterial chemoembolization: the results of 85 recurrent tumors in 35 patients.
    Tezuka M; Hayashi K; Okada Y; Irie T; Ina H
    Dig Dis Sci; 2009 Mar; 54(3):661-9. PubMed ID: 18649138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree models.
    Vosshenrich J; Zech CJ; Heye T; Boldanova T; Fucile G; Wieland S; Heim MH; Boll DT
    Eur Radiol; 2021 Jun; 31(6):4367-4376. PubMed ID: 33274405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter arterial chemoembolization with an interventional-CT system for recurrent hepatocellular carcinoma after living donor liver transplantation.
    Yamagami T; Yoshimatsu R; Ishikawa M; Kajiwara K; Aikata H; Tashiro H; Kakizawa H; Toyoda N; Ohdan H; Awai K
    Hepatogastroenterology; 2014; 61(133):1387-92. PubMed ID: 25436316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis.
    Li CP; Chao Y; Chen LT; Lee RC; Lee WP; Yuan JN; Yen SH; Lee SD
    Scand J Gastroenterol; 2008 Aug; 43(8):992-9. PubMed ID: 19086281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
    Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
    AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of texture analysis in evaluating liver cancer recurrence after transarterial chemoembolization].
    Wang R; Yang XY; Wang KY; Wang S; Li Q; Wu JF; Xu HT; Dai Y; Han CP; Xu K; Chen GH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):200-204. PubMed ID: 28482407
    [No Abstract]   [Full Text] [Related]  

  • 14. Postoperative recurrence of hepatocellular carcinoma: results of transcatheter arterial chemoembolization.
    Park JH; Han JK; Chung JW; Han MC; Kim ST
    Cardiovasc Intervent Radiol; 1993; 16(1):21-4. PubMed ID: 8382109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
    Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
    Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sloughing of intraductal tumor thrombus of hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Okuda M; Miyayama S; Yamashiro M; Yoshie Y; Sugimori N; Igarashi S; Nakashima Y; Sanada T; Kosaka S; Toya D; Matsui O
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):619-23. PubMed ID: 19609604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation.
    Najmi Varzaneh F; Pandey A; Aliyari Ghasabeh M; Shao N; Khoshpouri P; Pandey P; Zarghampour M; Fouladi D; Liddell R; Anders RA; Kamel IR
    Eur Radiol; 2018 Jul; 28(7):3032-3040. PubMed ID: 29383518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety margins of hepatocellular carcinoma demonstrated by 3-dimensional fused images of computed tomographic hepatic arteriography/unenhanced computed tomography: prognostic significance in patients who underwent transcatheter arterial chemoembolization.
    Tajima T; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Kakihara D; Honda H
    J Comput Assist Tomogr; 2010; 34(5):712-9. PubMed ID: 20861774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent hepatocellular carcinoma after transcatheter arterial chemoembolization: planning sonography for radio frequency ablation.
    Min JH; Lee MW; Rhim H; Choi D; Kim YS; Kim YJ; Cha DI; Lim HK
    J Ultrasound Med; 2011 May; 30(5):617-24. PubMed ID: 21527609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of diffusion-weighted imaging in evaluating therapeutic efficacy after transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Kubota K; Yamanishi T; Itoh S; Murata Y; Miyatake K; Yasunami H; Morio K; Hamada N; Nishioka A; Ogawa Y
    Oncol Rep; 2010 Sep; 24(3):727-32. PubMed ID: 20664980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.